Adverum Biotechnologies Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, announced the appointment of Christopher J. DeRespino as chief business officer.

Med Ad News had a chat with Bill McEllen, partner at Fingerpaint, who has been named lead of all advertising offices for the agency.

Fingerpaint, a full-service health and wellness marketing agency with five offices across the United States and more than 400 employees, named Fingerpaint partner Bill McEllen to lead its four advertising offices located in Saratoga Springs, N.Y.; Conshohocken, Pa.; Cedar Knolls, N.J.; and Phoenix, Ariz.

Fingerpaint, a full-service health and wellness marketing agency with five offices across the United States and over 400 employees, appointed industry veteran Beth Beck to lead the Saratoga Springs office and become a member of the Fingerpaint Operating Board.

Fingerpaint named industry veteran Laura Yoars as the head of account service in the full-service health and wellness marketing agency’s Cedar Knolls, N.J., office.

BioTheryX Inc., a clinical stage company focused on degrading proteins to create life-saving medicines, chose experienced biotechnology leader Robert F. Williamson III as president and CEO and a member of the BioTheryX board of directors. 

Florian Dieckmann joined Grünenthal as the new VP and head of global communications.

Immunotherapy company 3T Biosciences picked John Connolly, Ph.D., as interim CEO.

Eugene Schneider, M.D., was promoted to executive VP and chief clinical development officer of Ionis Pharmaceuticals Inc.

Brian Kotzin, M.D., was appointed as interim chief medical officer, head of development at Nektar Therapeutics.